A Case of Yellow Fever Vaccine-associated Viscerotropic Disease in Ecuador

Overview

Journal Am J Trop Med Hyg

Specialty Tropical Medicine

Date 2010 Mar 30

PMID 20348528

Citations 4

Authors

Richard W Douce

Diana Freire

Betzabe Tello

Gavino A Vasquez

Affiliations

Soon will be listed here.

Abstract

We report the first case of viscerotropic syndrome in Ecuador. Because of similarities between yellow fever and viscerotropic syndrome, the incidence of this recently described complication of vaccination with the 17D yellow fever vaccine is not known. There is a large population in South America that is considered at risk for possible reemergence of urban yellow fever. Knowledge of potentially fatal complications of yellow fever vaccine should temper decisions to vaccinate populations where the disease is not endemic.

Citing Articles

Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report.

Volkov L, Grard G, Bollaert P, Durand G, Cravoisy A, Conrad M BMC Infect Dis. 2020; 20(1):116.

PMID: 32041533 PMC: 7011288. DOI: 10.1186/s12879-020-4838-x.

Yellow fever vaccine-associated viscerotropic disease: current perspectives.

Thomas R Drug Des Devel Ther. 2016; 10:3345-3353.

PMID: 27784992 PMC: 5066857. DOI: 10.2147/DDDT.S99600.

High-throughput multiplexed xMAP Luminex array panel for detection of twenty two medically important mosquito-borne arboviruses based on innovations in synthetic biology.

Glushakova L, Bradley A, Bradley K, Alto B, Hoshika S, Hutter D J Virol Methods. 2015; 214:60-74.

PMID: 25680538 PMC: 4485418. DOI: 10.1016/j.jviromet.2015.01.003.

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Gershman M, Staples J, Bentsi-Enchill A, Breugelmans J, Brito G, Camacho L Vaccine. 2012; 30(33):5038-58.

PMID: 22561144 PMC: 3425393. DOI: 10.1016/j.vaccine.2012.04.067.

References

Martin M, Weld L, Tsai T, Mootrey G, Chen R, Niu M . Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerg Infect Dis. 2001; 7(6):945-951. PMC: 2631902. DOI: 10.3201/eid0706.010605. View

Engel A, Vasconcelos P, McArthur M, Barrett A . Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine. 2006; 24(15):2803-9. DOI: 10.1016/j.vaccine.2006.01.009. View

P Monath T . Dengue and yellow fever--challenges for the development and use of vaccines. N Engl J Med. 2007; 357(22):2222-5. DOI: 10.1056/NEJMp0707161. View

Wilder-Smith A, Hill D, Freedman D . The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practice. Am J Trop Med Hyg. 2008; 78(3):359-60. View

P Monath T, Cetron M . Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis. 2002; 34(10):1369-78. DOI: 10.1086/340104. View

Lindsey N, Schroeder B, Miller E, Braun M, Hinckley A, Marano N . Adverse event reports following yellow fever vaccination. Vaccine. 2008; 26(48):6077-82. DOI: 10.1016/j.vaccine.2008.09.009. View

. Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002. MMWR Morb Mortal Wkly Rep. 2002; 51(44):989-93. View

Kramer L, Li J, Shi P . West Nile virus. Lancet Neurol. 2007; 6(2):171-81. DOI: 10.1016/S1474-4422(07)70030-3. View

Martin M, Tsai T, Cropp B, Chang G, Holmes D, Tseng J . Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet. 2001; 358(9276):98-104. DOI: 10.1016/s0140-6736(01)05327-2. View

10.

Barnett E . Yellow fever: epidemiology and prevention. Clin Infect Dis. 2007; 44(6):850-6. DOI: 10.1086/511869. View

11.

Munoz J, Vilella A, Domingo C, Nicolas J, de Ory F, Corachan M . Yellow fever-associated viscerotropic disease in Barcelona, Spain. J Travel Med. 2008; 15(3):202-5. DOI: 10.1111/j.1708-8305.2008.00209.x. View

12.

Bae H, Domingo C, Tenorio A, de Ory F, Munoz J, Weber P . Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis. 2008; 197(11):1577-84. DOI: 10.1086/587844. View

13.

Whittembury A, Ramirez G, Hernandez H, Ropero A, Waterman S, Ticona M . Viscerotropic disease following yellow fever vaccination in Peru. Vaccine. 2009; 27(43):5974-81. DOI: 10.1016/j.vaccine.2009.07.082. View